✦ LIBER ✦

Antiplatelet Drugs — Do We Need New Options?

✍ Scribed by Professor Sergio Coccheri

Book ID: 119930881
Publisher: Springer International Publishing AG
Year: 2010
Tongue: English
Weight: 232 KB
Volume: 70
Category: Article
ISSN: 0012-6667
DOI: 10.2165/11536000-000000000-00000

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

DO WE NEED NEW DRUGS TO TREAT HYPERTENSI

DO WE NEED NEW DRUGS TO TREAT HYPERTENSION?

✍ C.J. DICKINSON 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 264 KB

Do we really need new anti-infective dru

Do we really need new anti-infective drugs?

✍ Louis B Rice 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 105 KB

Do we need new drugs against human Afric

Do we need new drugs against human African trypanosomiasis?

✍ Stich, August; Ponte-Sucre, Alicia; Holzgrabe, Ulrike 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 286 KB

Do we need anti-obesity drugs?

✍ Hainer, Vojtěch; Hainerová, Irena Aldhoon 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 133 KB

Do we need more iron-chelating drugs?

✍ George J Kontoghiorghes 📂 Article 📅 2003 🏛 The Lancet 🌐 English ⚖ 65 KB

Do We Need New Antidepressants?

✍ I. Hindmarch 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 136 KB

Tolerability and ecacy are important factors determining the choice of an antidepressant. Older tricyclic antidepressants (TCAs) are associated with signi®cant behavioural toxicity, notably psychomotor and cognitive impairment and sedation. These eects are not seen with newer TCAs and selective sero